Pay in 4 interest-free payments of $7.45 Learn more
Ships within 48 hours · Estimated delivery Oct 22 - Oct 27
Tirzepatide (Mounjaro, Zepbound) is a dual GIP/GLP-1 receptor agonist approved by the FDA for type 2 diabetes and chronic weight management
Every order ships free with no minimum including standalone BAC water orders
The primary mechanism behind 5-Amino-1MQ involves blocking the NNMT enzyme (nicotinamide N-methyltransferase)
Researchers use 5-Amino-1MQ to explore NNMT inhibition and its effects on downstream molecular signaling in controlled experimental models
We do not diagnose or treat conditions identified
US$ 29.18
US$ 20.30
US$ 24.16
US$ 26.94
US$ 27.15
US$ 24.84
US$ 28.32
US$ 20.17
